Nannan Zhang

Senior Director, Translational & Biomarker Research Abbisko Therapeutics

Seminars

Wednesday 12th November 2025
Harnessing Next Generation Sequencing to Advance FGFR Inhibitor Development
4:10 pm
  • Overview of the development history of FGFR inhibitors
  • Exploring the role of next generation sequencing in accelerating FGFR inhibitor discovery and development
  • Showcasing a case study from the early-stage development of an FGFR inhibitor
Nannan Zhang